51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215

12 trials found

diseases per page:

Showing 1 to 10 of 12 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-001265-28-IT (EUCTR)	02/03/2010	07/12/2009	Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144topical adm ...	Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144topical adm ...	skin fibrosis of systemic sclerosis patients MedDRA version: 12.1;Level: LLT;Classification code 100 ...	Product Name: P144 . Cytokines Inhibitors Product Code: P144 INN or Proposed INN: P144 Cytokines Inhibit ...	ISDIN S.A.	NULL	Not Recruiting			Female: yes Male: yes	98		Hungary;United Kingdom;Germany;Spain;Italy
2	EUCTR2007-002015-38-IT (EUCTR)	05/06/2009	19/06/2009	Phase II, multicenter, randomized, double-blind, intraindividually placebo controlled clinical trial ...	Phase II, multicenter, randomized, double-blind, intraindividually placebo controlled clinical trial ...	Skin Fibrosis in patients with systemic sclerosis MedDRA version: 12.0;Level: LLT;Classification cod ...	Product Name: P144	ISDIN S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	98	Phase 2	Hungary;Germany;United Kingdom;Spain;Italy
3	EUCTR2008-001265-28-GB (EUCTR)	14/11/2008	19/08/2008	Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical ad ...	Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical ad ...	Skin fibrosis in patients with systemic sclerosis MedDRA version: 9.1;Level: LLT;Classification code ...	Product Name: P144 Product Code: P144 . Cytokines Inhibitors INN or Proposed INN: P144 Other descriptive ...	ISDIN	NULL	Not Recruiting			Female: yes Male: yes	98		Hungary;Germany;United Kingdom;Spain;Italy
4	EUCTR2008-001265-28-DE (EUCTR)	13/10/2008	19/05/2008	OFFENE (UNVERBLINDETE) VERLÄNGERUNGSTUDIE FÜR PATIENTEN AUS DER ISD002-P144-07 STUDIE MIT TOPISCH AU ...	OFFENE (UNVERBLINDETE) VERLÄNGERUNGSTUDIE FÜR PATIENTEN AUS DER ISD002-P144-07 STUDIE MIT TOPISCH AU ...	Skin fibrosis in patients with systemic sclerosis MedDRA version: 9.1;Level: LLT;Classification code ...	Product Name: P144 Product Code: P144Cytokine Inhibitor INN or Proposed INN: P144 Other descriptive nam ...	ISDIN	NULL	Not Recruiting			Female: yes Male: yes	98		Hungary;Spain;Germany;Italy;United Kingdom
5	EUCTR2008-001265-28-HU (EUCTR)	18/09/2008	05/08/2008	Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144topical adm ...	Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144topical adm ...	Skin fibrosis in patients with systemic sclerosis.Szisztémás szklerózisban szenvedo betegek. MedDRA ...	Product Name: P144 Product Code: P144 Cytokines Inhibitors INN or Proposed INN: P144 Other descriptive n ...	ISDIN	NULL	Not Recruiting			Female: yes Male: yes	98		Hungary;United Kingdom;Germany;Spain;Italy
6	NCT00781053 (ClinicalTrials.gov)	July 2008	24/10/2008	Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study	Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study With P144Topical Adm ...	Skin Fibrosis	Drug: P144 cream	ISDIN	Digna Biotech S.L.	Completed	18 Years	65 Years	Both	38	Phase 2	Germany;Hungary;Italy;Poland;Spain;United Kingdom
7	EUCTR2008-001265-28-ES (EUCTR)	17/06/2008	08/04/2008	Estudio abierto de extensión con P144para la ampliación del tratamiento tópico de la fibrosis cutáne ...	Estudio abierto de extensión con P144para la ampliación del tratamiento tópico de la fibrosis cutáne ...	Fibrosis cutánea de pacientes con esclerosis sistémicaSkin fibrosis in patients with systemic sclero ...	Product Name: P144 Product Code: P144 . Cytokines Inhibitors INN or Proposed INN: P144 Other descriptive ...	ISDIN	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	98		Hungary;United Kingdom;Germany;Spain;Italy
8	EUCTR2007-002015-38-DE (EUCTR)	20/12/2007	03/08/2007	PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL ...	PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL ...	SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS MedDRA version: 9.1;Level: LLT;Classification code ...	Product Name: P144 Product Code: P144 Other descriptive name: DIGNA P144 CREAM	ISDIN	NULL	Not Recruiting			Female: yes Male: yes	98	Phase 2	Hungary;Spain;Germany;Italy;United Kingdom
9	EUCTR2007-002015-38-GB (EUCTR)	19/12/2007	31/07/2007	PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL ...	PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL ...	SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS MedDRA version: 9.1;Level: LLT;Classification code ...	Product Name: P144 DIGNA CREAM Product Code: P144 Other descriptive name: DIGNA P144 CREAM	ISDIN	NULL	Not Recruiting			Female: yes Male: yes	98	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Hungary;Spain;Germany;Italy;United Kingdom
10	EUCTR2007-002015-38-HU (EUCTR)	04/09/2007	09/07/2007	Phase II, multicenter, randomized, double-blind, intraindividually placebo controlled clinical trial ...	Phase II, multicenter, randomized, double-blind, intraindividually placebo controlled clinical trial ...	SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS MedDRA version: 9.1;Level: LLT;Classification code ...	Product Name: P144 Product Code: P144 Other descriptive name: DIGNA P144 CREAM	ISDIN	NULL	Not Recruiting			Female: yes Male: yes	98	Phase 2	Hungary;Germany;United Kingdom;Spain;Italy

First Previous1 2Next Last